Medigus Announces Corporate Rebranding and Launch of New Website
October 12 2021 - 8:15AM
Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in
advanced medical solutions, innovative internet technologies and
electric vehicle and charging solutions, today announced it has
completed a corporate rebranding process, including but not limited
to, a new brand logo, a new website and an investor lobby,
http://www.medigus.com/.
Medigus’ corporate rebranding reflects the
Company’s business direction and plans for positioning itself as an
innovative technology company, which is aligned with its strategic
targets to provide a greater return to our shareholders.
On the new website, Medigus’ partners and
investors can find information regarding all of Medigus’
activities: Charging Robotics Ltd. (100%), Revoltz Ltd. (19.99%),
Polyrizon Ltd. (35.86%), ScoutCam Inc. (OTCQB:SCTC) (27.76%),
Jeff’s Brands Ltd. (50.03%), Gix Internet Ltd. (TASE: GIX) (33.17%)
and Eventer Technologies Ltd. (47.69%).
Medigus recently announced record
financial results for the six months ended June 30, 2021. Revenues
reached a record high, and totaled $2,393,000. Net income for the
period reached a record of $7,927,000. Shareholders’ equity totaled
$53,904,000 in cash, and cash equivalents totaled $29,642,000 as of
June 30, 2021.
About Medigus
Based in Israel, Medigus Ltd. (Nasdaq: MDGS) is
a technology company that is focused on innovative growth
partnerships, mainly in advanced medical solutions, digital
commerce, and electric vehicle markets. Medigus’ affiliations in
the medical solutions arena consist of ownership in ScoutCam
(OTCQB: SCTC) Inc., and Polyzion Ltd. The Company’s affiliates in
digital commerce include Gix Internet Ltd. (TASE:GIX), Jeff's
Brands Ltd. and Eventer Technologies Ltd. In the electric vehicle
market, Charging Robotics Ltd. and Revoltz are also part of the
Company’s portfolio of technology solution providers. Medigus is
traded on the Nasdaq Capital Market. To learn more about Medigus’
advanced technologies, please
visit http://www.medigus.com/
Cautionary Note Regarding Forward Looking
Statements
This press release may contain statements that
are “Forward-Looking Statements,” which are based upon the current
estimates, assumptions and expectations of Medigus’ management and
its knowledge of the relevant market. The company has tried, where
possible, to identify such information and statements by using
words such as “anticipate,” “believe,” “envision,” “estimate,”
“expect,” “intend,” “may,” “plan,” “predict,” “project,” “target,”
“potential,” “will,” “would,” “could,” “should,” “continue,”
“contemplate” and other similar expressions and derivations thereof
in connection with any discussion of future events, trends or
prospects or future operating or financial performance, although
not all forward-looking statements contain these identifying words.
For example, Medigus uses forward looking statements when
describing revenue aspirations. These forward-looking statements
represent Medigus’ expectations or beliefs concerning future
events, and it is possible that the results described in this press
release will not be achieved. By their nature, Forward-Looking
Statements involve known and unknown risks, uncertainties and other
factors which may cause future results of Medigus’ activity to
differ significantly from the content and implications of such
statements. Other risk factors affecting Medigus are discussed in
detail in Medigus’ filings with the Securities and Exchange
Commission. Forward-Looking Statements are pertinent only as of the
date on which they are made, and Medigus undertakes no obligation
to update or revise any Forward-Looking Statements, whether as a
result of new information, future developments or otherwise.
Neither Medigus nor its shareholders, officers and employees, shall
be liable for any action and the results of any action taken by any
person based on the information contained herein, including without
limitation the purchase or sale of Medigus’ securities. Nothing in
this press release should be deemed to be medical or other advice
of any kind.
Contact
Tali Dinar
Chief Financial Officer
+972-8-6466-880
ir@medigus.com
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Apr 2024 to May 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From May 2023 to May 2024